UNSPSC 51285804: Hexamine mandelate

This classification denotes a urinary anti-infective agent with the molecular formula C8H8O3.C6H12N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 695N30CINR, chemically known as 1,3,5,7-tetraazatricyclo(3.3.1.1(3,7))decane, mono(alpha-hydroxybenzeneacetate) but more generally known as hexamine mandelate, which bears US NIH Compound Identifier 11478. European Medicines Agency schedules Methenamine mandelate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03216MIG.

Most nations schedule hexamine mandelate under HS 29339990. SMILES: C1CCC(CC1)C(C(=O)O)O.C1N2CN3CN1CN(C2)C3.

UNSPSC 51285804 Hexamine mandelate is a Commodity code for a pharmaceutical active ingredient; recent state and local solicitations tagged under this code, however, show little alignment with its nominal scope. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, which are finished antibiotics, not hexamine mandelate. Seminole County, Florida released an IFB for Naloxone and Safe Drug Deactivation Systems, procuring 1,900 units of Naloxone and 800 deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida — again, finished pharmaceutical products and safety equipment, not the active ingredient named by the code. These recent opportunities reflect state health departments and county public health agencies sourcing finished pharmaceuticals and emergency-response supplies through competitive bidding and cooperative purchasing vehicles, not procurement of hexamine mandelate as a raw material or intermediate.

The code shows minimal recent activity specifically targeting hexamine mandelate. The two state and local opportunities posted between June and August 2026 are misaligned with the code's nominal classification, suggesting either tagging error or very low volume in hexamine mandelate procurement at the state and local level. Geographic activity appears limited to Florida and Illinois based on these records. Businesses pursuing this code should verify whether state and local agencies actively source hexamine mandelate directly or whether pharmaceutical procurement under this code is incidental to broader finished-drug acquisitions.